|
CN101654441A
|
|
Anticoagulant compound, composition and application thereof
|
|
CN101654405A
|
|
Anticoagulant compound, composition and application thereof
|
|
CN101654446A
|
|
Anticoagulant compound, composition and application thereof
|
|
CN101654427A
|
|
Anticoagulant compound, composition and application thereof
|
|
CN101333294A
|
|
Biodegradable triblock copolymer with invertible thermal gelling property
|
|
CN101225371A
|
|
Preparation technology of recombinant human p43 protein
|
|
CN101095680A
|
|
Preparations containing rosuvastatin calcium and amlodipine and method for preparing the same
|
|
CN101025409A
|
|
Method for determining impurities for paracetamol and tramadol hydrochloride preparation
|
|
CN1981760A
|
|
Injection tyxolazo and its making method
|
|
CN1954855A
|
|
Eye preparation containing sodium hyaluronate for treating fundus macular degeneration and its preparation method
|
|
CN1955173A
|
|
High purity cortex fraxini and its preparation method
|
|
CN1899286A
|
|
Racanisodamine eye drops
|
|
CN1887290A
|
|
Lincomycin hydrochloride composition and its prepn
|
|
CN1803128A
|
|
Oral disintegrating tablet containing tramadol hydrochloride and acetaminopher, and its preparation method
|
|
CN1795856A
|
|
Medicinal preparation of containing Tenatoprazole and preparation method
|
|
CN1636568A
|
|
Eye drop of tobramycin and sodium hyaluronate and its prepn process
|
|
CN1498617A
|
|
Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method
|
|
CN1156023A
|
|
Triazazole nucleoside aerosol and its preparing method
|
